The new drug combinations: Their place in the treatment of uncomplicated Plasmodium falciparum malaria

Fundamental and Clinical Pharmacology

Volumn 17, Issue 2, 2003, Pages 155-160

  Danis, Martin ^a,b   Bricaire, François ^a  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antimalarial drug combinations; Chemoresistance; Falciparum malaria

Indexed keywords

AMODIAQUINE; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; BENFLUMETOL; CHLORPROGUANIL PLUS DAPSONE; DAPSONE; DIHYDROARTEMISININ; FANSIDAR; MEFLOQUINE; PIPERAQUINE; PROGUANIL; PYRIMETHAMINE; PYRONARIDINE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; HUMAN; MALARIA FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; ARTEMISININS; ATOVAQUONE; CHLOROGUANIDE; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FLUORENES; HUMANS; MALARIA, FALCIPARUM; NAPHTHOQUINONES; SESQUITERPENES;

EID: 0037397498     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-8206.2003.00165.x     Document Type: Article

References (18)

1. Snow R.W., Craig M., Deichmann U., Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull. World Health Organ. (1999) 77 624-640.
2. White N.J., Nosten F., Looareesuwan S. et al. Averting a malaria disaster. Lancet (1999) 353 1965-1967.
3. Olliaro P.L., Nevill C., Le Bras J. et al. Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet (1996) 348 1196-1201.
4. Ridley R.G. Medical needs, scientific opportunity and the drive for antimalarial drugs. Nature. Feb. 7, (2002) 415 686-693.
5. Anonymous. Antimalarial drug combination therapy. Report of a WHO technical consultation. April 4-5, 2001. WHO/CDS/RBM/2001.35. 40p.
6. White N.J. Why is it antimalarial drug treatments do not always work? Ann. Trop. Med. Parasit. (1998) 92 449-458.
7. Bouchaud O., Monlun E., Muanza K. et al. Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in nonimmune adults: a randomized comparative trial. Am. J. Trop. Med. Hyg. (2000) 63 274-279.
8. Hogh B., Clarke P.D., Camus D. et al. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune travelers: a randomized, double-blind study. Lancet (2000) 356 1888-1894.
9. Overbosch D., Schilthuis H., Bienzle U. et al. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin. Infect. Dis (2001) 33 1015-1021.
10. Van Vugt M., Brockman A., Gemperli B. et al. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob. Agents Chemother. (1998) 42 135-139.
11. Van Agtmael M., Bouchaud O., Malvy D. et al. CGP 56697 Study Group. The comparative efficacy and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travelers returning from the Tropics to The Netherlands and France. Int. J. Antimicrob. Agents. (1999) 12 159-169.
12. Van Vugt M., Looreesuwan S., Wilairatana P. et al. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. (2000) 94 545-548.
13. Brockman A., Price R.N., VanVugt M. et al. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans. R. Soc. Trop. Med. Hyg. (2000) 94 537-544.
14. Adjuik M., Agnamey P., Babiker A. et al. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomized, multicenter trial. Lancet (2002) 359 1365-1372.
15. Von Seidlein L., Milligan P., Pinder M. et al. Efficacy of artesunate plus pyrimethamine-sulfadoxine for uncomplicated malaria in Gambian children: a double-blind, randomized, controlled trial. Lancet (2000) 355 352-357.
16. Basco L.K., Same Ekobo A., Foumane Ngane V. et al. Therapeutic efficacy of sulfadoxine-pyrimethamine amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bull. World Health Organ. (2002) 80 538-545.
17. Mutabingwa T., Nzila A., Mberu E. et al. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 2001 358 1218-1223.
18. Sulo J., Chimpeni P., Hatcher J. et al. Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomized clinical trial. Lancet (2002) 360 1136-1143.